Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Starting treatment news

Show

From To
HIV Treatment During Primary Infection Raises CD4s - and Further Questions

Two new studies, each published in The New England Journal of Medicine (NEJM), suggest that treating HIV with antiretrovirals (ARVs) within four to six months after infection helps raise CD4 counts, but neither study was able to make an overwhelming argument for starting therapy so early.

Published
23 January 2013
From
AIDSMeds
Nigeria: Drug resistance data show merits of using tenofovir in first-line ART regimens

People living with HIV in Nigeria, at high risk for virological failure, on a tenofovir (TDF)-based first-line regimen, had fewer nucleoside reverse transcriptase inhibitor (NRTI) drug-resistant mutations

Published
23 January 2013
By
Carole Leach-Lemens
BHIVA and EAGA position statement on the use of antiretroviral therapy to reduce HIV transmission: January 2013

The UK Department of Health, in collaboration with the Expert Advisory Group on AIDS and the British HIV Association, has issued a definitive statement on the potential of antiretroviral therapy to reduce HIV infectiousness and transmission. It says that the risk of transmission from a person with a fully-suppressed viral load in the absence of STIs is "extremely low" and advises physicians to discuss this with all patients.

Published
22 January 2013
From
Department of Health
Australian researchers project that many HIV-positive people will run out of treatment options

Running out of antiretroviral treatment options may severely curtail the life expectancy of people with HIV in resource-rich countries, according to Australian research published in

Published
22 January 2013
By
Michael Carter
Early HIV drugs 'slow virus down'

Giving a patient HIV drugs as soon as they are diagnosed could be the future of treatment, say researchers.

Published
17 January 2013
From
BBC Health
FDA approves prescribing information update for EDURANT® (rilpivirine)

On December 7, 2012, FDA approved changes to the Edurant (rilpivirine) package insert. The major changes include restricting the indication to treatment-naïve adult patients with HIV-1 RNA less than or equal to 100,000 copies/mL, updating the package insert with the 96 week results from the Phase 3 trials and adding a new Warning and Precaution for hepatotoxicity.

Published
11 December 2012
From
Janssen press release
Antiretroviral treatment for HIV reduces food insecurity, study finds

Can treatment with modern anti-HIV drugs help fight hunger for HIV-infected patients in Africa? Starting antiretroviral therapy for HIV reduces "food insecurity" among patients in Uganda, suggests a new study.

Published
06 December 2012
From
Science Daily
Out-of-clinic adherence club for delivery of ARVs shows better retention than standard of care

An out-of-clinic model of HIV treatment delivery in South Africa has shown superior results to the standard in-clinic delivery of antiretrovirals (ARVs), according to results of

Published
03 December 2012
By
Lesley Odendal
South Africa: HIV Patients to Take One ARV Tablet Daily

As from April next year, patients who are on ARV treatment will no longer have to take three tablets but only need one tablet per day.

Published
30 November 2012
From
AllAfrica
HIV and TB in Practice for nurses: Starting ART for treatment and prevention in people with active TB and HIV

This article provides information for nurses on starting HIV treatment for people with HIV and active TB.

Published
29 November 2012
From
HIV & AIDS treatment in practice

Filter by country